Preclinical trials of a new radiopharmaceutical for the treatment of ovarian cancer have shown promising results, with tumor growth and mass significantly reduced after use. The new radiopharmaceutical, which is
Monoamine oxidase inhibitors are a type of medicine used to treat depression. They operate by increasing levels of serotonin, the brain’s “happy hormone.” According to a recent UCLA study, such
This 1974 microscope image made available by the Centers for Disease Control and Prevention shows changes in cells indicative of adenocarcinoma of the prostate. In results released Thursday, June 3, 2021 by the American Society of Clinical Oncology, doctors are reporting improved survival in men with advanced prostate cancer from an experimental drug that delivers radiation directly to tumor cells. (Dr. Edwin P. Ewing, Jr./CDC via AP)
The Food and Drug Administration (FDA) has granted approval for a novel imaging agent that can identify prostate cancer after it has spread to other regions of the body. According
A research group out of the Biomedical Engineering Department at the University of Houston have demonstrated the ability to train a standard laptop to identify diseased skin with extreme accuracy.